Inhalation of xenon-gas: Time it takes for the body to eliminate xenon after inhalation and the effect of xenon on Erythropoetin-levels in the blood of healthy volunteers.
- Conditions
- Healthy volunteersTherapeutic area: Body processes [G] - Physiological processes [G07]
- Registration Number
- EUCTR2014-000973-38-DE
- Lead Sponsor
- RWTH Aachen vertreten durch das CTC-A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 144
Male subjects, age >18 years, legally competent to sign, without any known medical condition or medication prescribed at the Uniklinik RWTH Aachen
Persons that are able and willing to understand and follow the instructions of the study personnel.
Signed informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 144
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Smoker, alcoholic or person who regularly consumes drugs or medication.
Persons with a medical condition that is contraindicated with the planned treatment.
Known hypersensivity against xenon.
Persons not legally competent to sign.
Simultaneous participation at any other trial.
Blood-loss due to trauma during the period of the study or 2 months previous.
Blood donation during the period of the study or 2 months previous.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method